Capecitabine monotherapy in advanced breast cancer resistant to anthracycline and taxane: A meta-analysis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Works matching AU Zhanyu Pan
Results: 28
1
2
Utilizing a novel model of PANoptosis-related genes for enhanced prognosis and immune status prediction in kidney renal clear cell carcinoma.
- Published in:
- Apoptosis, 2024, v. 29, n. 5/6, p. 681, doi. 10.1007/s10495-023-01932-3
- By:
- Publication type:
- Article
3
Traditional Chinese medicine formula 01 for nasopharyngeal carcinoma (NPC01) for head & neck cancer and health-related quality of life: a retrospective study.
- Published in:
- BMC Complementary Medicine & Therapies, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12906-022-03699-7
- By:
- Publication type:
- Article
4
Progression-Free Survival and Time to Progression as Real Surrogate End Points for Overall Survival in Advanced Breast Cancer: A Meta-Analysis of 37 Trials.
- Published in:
- 2018
- By:
- Publication type:
- journal article
5
Progression-Free Survival and Time to Progression as Real Surrogate End Points for Overall Survival in Advanced Breast Cancer: A Meta-Analysis of 37 Trials.
- Published in:
- Clinical Breast Cancer, 2018, v. 18, n. 1, p. 63, doi. 10.1016/j.clbc.2017.07.015
- By:
- Publication type:
- Article
6
Rhamnetin induces apoptosis in human breast cancer cells via the miR-34a/Notch-1 signaling pathway.
- Published in:
- Oncology Letters, 2019, v. 17, n. 1, p. 676
- By:
- Publication type:
- Article
7
Sophoridine suppresses cell growth in human medulloblastoma through FoxM1, NF‑κB and AP‑1.
- Published in:
- Oncology Letters, 2017, v. 14, n. 6, p. 7941, doi. 10.3892/ol.2017.7224
- By:
- Publication type:
- Article
8
Anlotinib optimizes anti-tumor innate immunity to potentiate the therapeutic effect of PD-1 blockade in lung cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 12, p. 2523, doi. 10.1007/s00262-020-02641-5
- By:
- Publication type:
- Article
9
From complexity to clarity: development of CHM-FIEFP for predicting effective components in Chinese herbal formulas by using big data.
- Published in:
- Cancer Biology & Medicine, 2024, v. 21, n. 11, p. 1, doi. 10.20892/j.issn.2095-3941.2023.0442
- By:
- Publication type:
- Article
10
Optimal therapy for concomitant EGFR and TP53 mutated non-small cell lung cancer: a real-world study.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-10637-4
- By:
- Publication type:
- Article
11
A case of tonsillar metastasis from breast cancer and literature review.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
12
Epifriedelinol Ameliorates DMBA-Induced Breast Cancer in Albino Rats by Regulating the PI3K/AKT Pathway.
- Published in:
- Tohoku Journal of Experimental Medicine, 2022, v. 257, n. 4, p. 283, doi. 10.1620/tjem.2022.J030
- By:
- Publication type:
- Article
13
Effect of Wellness Education on Quality of Life of Patients With Non--Small Cell Lung Cancer Treated With First-Line Icotinib and on Their Family Caregivers.
- Published in:
- Integrative Cancer Therapies, 2019, v. 18, p. 1, doi. 10.1177/1534735419842373
- By:
- Publication type:
- Article
14
Efficacy of Traditional Chinese Medicine in Treatment and Prophylaxis of Radiation-Induced Oral Mucositis in Patients Receiving Radiotherapy: A Randomized Controlled Trial.
- Published in:
- Integrative Cancer Therapies, 2018, v. 17, n. 2, p. 444, doi. 10.1177/1534735417725578
- By:
- Publication type:
- Article
15
Oxymatrine Inhibits Development of Morphine-Induced Tolerance Associated With Decreased Expression of P-glycoprotein in Rats.
- Published in:
- Integrative Cancer Therapies, 2010, v. 9, n. 2, p. 213, doi. 10.1177/1534735410369671
- By:
- Publication type:
- Article
16
Aumolertinib plus chemotherapy as first-line treatment for advanced NSCLC with EGFR exon 19 deletion or exon 21 L858R: a phase II trial.
- Published in:
- Oncologist, 2025, v. 30, n. 3, p. 1, doi. 10.1093/oncolo/oyae336
- By:
- Publication type:
- Article
17
Safety and Efficacy of Apatinib Monotherapy for Unresectable, Metastatic Esophageal Cancer: A Single‐Arm, Open‐Label, Phase II Study.
- Published in:
- Oncologist, 2020, v. 25, n. 10, p. e1464, doi. 10.1634/theoncologist.2020-0310
- By:
- Publication type:
- Article
18
Comparison of MRI and Ultrasound for Evaluation of Axillary Lymph Node Status in Early Breast Cancer.
- Published in:
- Cancer Management & Research, 2024, v. 16, p. 1685, doi. 10.2147/CMAR.S482484
- By:
- Publication type:
- Article
19
Baicalin reverses radioresistance in nasopharyngeal carcinoma by downregulating autophagy.
- Published in:
- Cancer Cell International, 2020, v. 20, n. 1, p. 1, doi. 10.1186/s12935-020-1107-4
- By:
- Publication type:
- Article
20
Icotinib alone or with bevacizumab as first‐line therapy in Chinese patients with advanced nonsquamous non‐small cell lung cancer and activating EGFR mutations: A retrospective study.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 17, p. 2369, doi. 10.1111/1759-7714.14079
- By:
- Publication type:
- Article
21
Efficacy of pemetrexed and carboplatin with or without bevacizumab in lung adenocarcinoma patients with EGFR non‐T790M mutations after progression on first‐line EGFR‐tyrosine kinase inhibitors.
- Published in:
- Thoracic Cancer, 2018, v. 9, n. 9, p. 1151, doi. 10.1111/1759-7714.12814
- By:
- Publication type:
- Article
22
Is lung involvement a favorable prognostic factor for pancreatic ductal adenocarcinoma with synchronous liver metastases?—A propensity score analysis.
- Published in:
- Expert Review of Gastroenterology & Hepatology, 2023, v. 17, n. 4, p. 405, doi. 10.1080/17474124.2023.2183497
- By:
- Publication type:
- Article
23
Clinicopathological characteristics, staging classification, and survival outcomes of primary malignant melanoma of the esophagus.
- Published in:
- Journal of Surgical Oncology, 2018, v. 117, n. 4, p. 588, doi. 10.1002/jso.24905
- By:
- Publication type:
- Article
24
Nomogram based on multiparametric analysis of early‐stage breast cancer: Prediction of high burden metastatic axillary lymph nodes.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 35, p. 3465, doi. 10.1111/1759-7714.15139
- By:
- Publication type:
- Article
25
Metabolic and Immunological Implications of MME<sup>+</sup>CAF-Mediated Hypoxia Signaling in Pancreatic Cancer Progression: Therapeutic Insights and Translational Opportunities.
- Published in:
- Biological Procedures Online, 2024, v. 26, n. 1, p. 1, doi. 10.1186/s12575-024-00254-1
- By:
- Publication type:
- Article
26
Clinicopathological Features, Staging Classification, and Clinical Outcomes of Esophageal Melanoma: Evaluation of a Pooled Case Series.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.858145
- By:
- Publication type:
- Article
27
Progress of PD-1/PD-L1 Inhibitors in Non-small Cell Lung Cancer.
- Published in:
- Chinese Journal of Lung Cancer, 2017, v. 20, n. 2, p. 138, doi. 10.3779/j.issn.1009-3419.2017.02.09
- By:
- Publication type:
- Article
28
Efficacy and Safety of Biosimilar SCT510 Compared with Bevacizumab for the First-Line Treatment of Advanced Non-Squamous Non-Small Cell Lung Cancer: A Randomized, Double-Blind, Phase III Study.
- Published in:
- Advances in Therapy, 2024, v. 41, n. 11, p. 4032, doi. 10.1007/s12325-024-02965-z
- By:
- Publication type:
- Article